Issues of new types of tobacco (e-cigarette and heat-not-burn tobacco): from the perspective of ‘tobacco harm reduction’
10.5124/jkma.2018.61.3.181
- Author:
Cheolmin LEE
1
;
Sungroul KIM
;
Yoo Seock CHEONG
Author Information
1. Department of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Tobacco;
Smoking cessation;
Electronic nicotine delivery systems;
Heat-not-burn
- MeSH:
Counseling;
Electronic Cigarettes;
Harm Reduction;
Korea;
Marketing;
Nicotine;
Smoking Cessation;
Social Control, Formal;
Tobacco Products;
Tobacco Use;
Tobacco;
World Health Organization
- From:Journal of the Korean Medical Association
2018;61(3):181-190
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
E-cigarettes, heat-not-burn (HNB) tobacco, and other new types of tobacco products are emerging in Korea. These products are particularly popular among smokers who are looking for less harmful means of tobacco consumption, and are highly relevant for existing tobacco control policies. E-cigarettes, which are electronic devices designed to allow the user to inhale nicotine as a vapor, are controversial in terms of their safety and effects on smoking cessation, as a variety of harmful substances have been detected in e-cigarette vapor. Due to policy differences in tobacco harm reduction, the regulations on e-cigarettes differ from country to country, and domestic regulations regulate e-cigarettes in a manner similar to conventional cigarettes. In contrast, HNB tobacco was introduced in Korea in June 2017, and is rapidly expanding in the market, as active marketing campaigns seek to communicate to consumers that HNB tobacco use involves no tar and is less harmful to health. However, the World Health Organization and several professional groups have argued that based on independent studies not supported by tobacco companies, HNB tobacco should be regulated in the same way as conventional cigarettes because there is no evidence that HNB tobacco is less harmful. Clinicians need to expand their understanding of new tobacco products so that they can provide appropriate counseling.
